CD48

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, CD48 mutation is significantly associated with the drug of many other genes, with 2 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible CD48-associated genes across cancer lineages are Afatinib and WZ4003. Each is linked with CD48 in more than 1 cancer types. Because this analysis shows association rather than direction, both CD48-to-partner and partner-to-CD48 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Afatinib grouped by CD48-low versus CD48-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CD48→partner) and Y-score (partner→CD48) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEAfatinib →+0.606+2.646.035.04711
LARGE_INTESTINEWZ4003 →+0.427+2.769.040.04011
Each partner links to its Q-omics profile. Showing the 2 strongest of 2 associations by consensus.

Afatinib by CD48 expression — LARGE_INTESTINE

Box plot of Afatinib in CD48-low vs CD48-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration